Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04409561 · ClinicalTrials.gov registry record
Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population
A clinical trial of Healthy and Sepsis, sponsored by Abionic.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT04409561 is a study of Healthy and Sepsis that has completed, run by Abionic. The registered enrollment target is 150 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04409561, a study of Healthy and Sepsis, has completed, sponsored by Abionic.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.
Conditions Studied
Interventions
- DEVICE Blood collection
Study Locations (1)
Ohio
- Mercy Health St. Vincent - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04409561
The ClinicalTrials.gov registry entry for NCT04409561 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The listed sponsor is Abionic, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Blood collection is the first listed.
NCT04409561 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04409561 about?
NCT04409561 is a clinical study titled "Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population". This is a single center, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.
What is the current status of trial NCT04409561?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2021-11-15. Estimated completion is 2022-01-15.
What conditions does trial NCT04409561 study?
This clinical trial studies the following conditions: Healthy, Sepsis, Septic Shock.
What interventions are being tested in trial NCT04409561?
The interventions under investigation include: Blood collection (DEVICE).
Who is sponsoring clinical trial NCT04409561?
This trial is sponsored by Abionic, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04409561 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.